Tectonic Therapeutic, Inc. Share Price

Tectonic Therapeutic, Inc. Share Price

NASDAQ: TECX | Small Cap
$21.09
-$0.98 (-4.46%) Last updated on 13 Nov, 2026 | 01:31 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Tectonic Therapeutic, Inc. Stock Performance

Open
$20.91
Prev. Close
$22.07
Circuit Range
N/A
Day Range
$20.91 - $21.50
Year Range
$17.24 - $38.71
Volume
2,351
Average Traded
$20.99

Tectonic Therapeutic, Inc. Share Price Today

As of 13 November 2026, Tectonic Therapeutic, Inc.'s share price is $21.09. The stock opened at $20.91, compared to its previous close of $22.07. During today's trading session, Tectonic Therapeutic, Inc.'s share price traded between $20.91 and $21.50, with an average price of $21.20. Over the past 52 weeks, the stock has recorded a high of $38.71 and a low of $17.24. In terms of performance, Tectonic Therapeutic, Inc.'s share price has declined by 32.29% over the last six months and is down 1.66% on a year-on-year basis.

Tectonic Therapeutic, Inc. Share Price Chart

Line chart of the Tectonic Therapeutic, Inc. price trend over the selected period. The price fell overall, ranging from 20.77 to 21.67, ending at 21.09.
$20.91$21.50
L
Show Current Price
H

Tectonic Therapeutic, Inc. Stock Fundamentals & Key Indicators

Market Cap
$386.33M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.51
Revenue (TTM)
$0.00
Return On Equity (TTM)
-38.42%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-11.02%

Tectonic Therapeutic, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$19.23-$25.24-$22.29-$21.35
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-31.25%11.69%4.22%

Tectonic Therapeutic, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$57.98-$74.15
Net Profit MarginN/AN/A
Income ChangeN/A-27.89%

About Tectonic Therapeutic, Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Tectonic Therapeutic, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$19.71
$21.43
+8.78%
Oct 2026
$23.29
$19.70
-14.01%
Sep 2026
$31.07
$22.91
-37.57%
Aug 2026
$27.38
$36.70
+30.63%
Jul 2026
$34.07
$28.09
-17.67%
Jun 2026
$30.29
$34.12
+9.57%
May 2026
$27.70
$31.14
+11.47%
Apr 2026
$31.37
$27.93
-9.89%
Mar 2026
$23.40
$31.00
+31.86%
Feb 2026
$20.59
$23.51
+17.79%
Jan 2026
$20.71
$19.96
-4.20%
Dec 2025
$21.36
$20.84
-2.82%

TECX Share Price FAQs